Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LYB001 Booster Vaccination in Adults
NCT05664932Phase 3Unknown
- Sponsor
- Patronus Biotech
- Start
- Dec 2022
- Primary completion
- Jan 2023
- Modality
- Recombinant Protein Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of recombinant sars-cov-2 vaccine (cho cell) lyb001 in coronavirus disease 2019 (COVID-19), sponsored by Patronus Biotech. Status: unknown.
02
Drugs
recombinant sars-cov-2 vaccine (cho cell) lyb001
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05664932.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05664932.